The estimated Net Worth of Kristen Williams is at least $5.99 Million dollars as of 12 June 2024. Ms. Williams owns over 7,452 units of Pacira BioSciences Inc stock worth over $1,337,856 and over the last 9 years she sold PCRX stock worth over $2,963,011. In addition, she makes $1,692,720 as Chief Administrative Officer and Secretary at Pacira BioSciences Inc.
Kristen has made over 25 trades of the Pacira BioSciences Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently she sold 7,452 units of PCRX stock worth $211,488 on 12 June 2024.
The largest trade she's ever made was exercising 83,577 units of Pacira BioSciences Inc stock on 15 September 2020 worth over $3,275,383. On average, Kristen trades about 7,232 units every 89 days since 2015. As of 12 June 2024 she still owns at least 102,912 units of Pacira BioSciences Inc stock.
You can see the complete history of Ms. Williams stock trades at the bottom of the page.
Kristen Williams J.D. serves as Chief Administrative Officer, Secretary of the Company. She previously served as our Vice President, General Counsel from March 2013 to October 2014, as corporate counsel from December 2011 to March 2013, and as a legal consultant to our Company beginning in April 2011. Prior to joining Pacira, she was Vice President, Corporate Compliance and Assistant General Counsel for Bioenvision, Inc. from June 2004 until its merger with Genzyme Corporation in 2007. Prior to that, she practiced corporate law at Paul Hastings LLP in New York from September 1999 to June 2004, where her practice encompassed all aspects of public and private mergers and acquisitions, corporate finance, and securities law and compliance, with a core focus in the healthcare industry. Ms. Williams holds a B.S. in Business Administration from Bucknell University and a J.D. from the University of Denver, College of Law.
As the Chief Administrative Officer and Secretary of Pacira BioSciences Inc, the total compensation of Kristen Williams at Pacira BioSciences Inc is $1,692,720. There are 3 executives at Pacira BioSciences Inc getting paid more, with David Stack having the highest compensation of $5,806,430.
Kristen Williams is 46, she's been the Chief Administrative Officer and Secretary of Pacira BioSciences Inc since 2014. There are 23 older and 1 younger executives at Pacira BioSciences Inc. The oldest executive at Pacira BioSciences Inc is Gary Pace, 72, who is the Independent Director.
Kristen's mailing address filed with the SEC is C/O PACIRA BIOSCIENCES, INC., 5401 WEST KENNEDY BOULEVARD, SUITE 890, TAMPA, FL, 33609.
Over the last 14 years, insiders at Pacira BioSciences Inc have traded over $321,391,130 worth of Pacira BioSciences Inc stock and bought 2,075,444 units worth $15,133,188 . The most active insiders traders include Advisors Llc Orbi Med Capit..., Carl L Gordon, and Andreas Wicki. On average, Pacira BioSciences Inc executives and independent directors trade stock every 13 days with the average trade being worth of $491,036. The most recent stock trade was executed by Marcelo Bigal on 16 August 2024, trading 1,512 units of PCRX stock currently worth $20,034.
pacira pharmaceuticals, inc. (nasdaq: pcrx) is an emerging specialty pharmaceutical company focused on the clinical and commercial development of new products that meet the needs of acute care practitioners and their patients. the company's current emphasis is the development of non-opioid products for postsurgical pain control, and its lead product, exparel® (bupivacaine liposome injectable suspension), was commercially launched in the united states in april 2012. exparel and two other products have utilized the pacira proprietary product delivery technology depofoam®, a unique platform that encapsulates drugs without altering their molecular structure and then releases them over a desired period of time.
Pacira BioSciences Inc executives and other stock owners filed with the SEC include: